A Multicentric, Double Blind, randomised, Comparative Phase III Study of the Efficacy of the new Wound Healing Solution Diperoxochloric acid (DPOCL, DermaPro) compared to isotonic Sodium Chloride Solution 0.9% in Patients with Diabetic Foot Ulcers

Trial Profile

A Multicentric, Double Blind, randomised, Comparative Phase III Study of the Efficacy of the new Wound Healing Solution Diperoxochloric acid (DPOCL, DermaPro) compared to isotonic Sodium Chloride Solution 0.9% in Patients with Diabetic Foot Ulcers

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Diperoxochloric acid (Primary) ; Sodium chloride
  • Indications Diabetic foot ulcer
  • Focus Registrational; Therapeutic Use
  • Sponsors Dermatools
  • Most Recent Events

    • 31 Oct 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
    • 26 Oct 2013 Actual initiation date changed from 2 Aug 2013 to 10 Oct 2013 as reported by European Clinical Trials Database.
    • 03 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top